Saturday 17 October 2026 Export PCRX’s income statement to Excel — free account

Pacira BioSciences, Inc.

PCRX Healthcare Drug Manufacturers Specialty & Generic

Pacira BioSciences, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $726.4 million, up 3.63% from fiscal 2024. In the quarter to June 2026, revenue grew 6.24%, EPS grew 209.1%, free cash flow grew 502.5% and total debt fell 37.4%, each against the same quarter a year earlier. Revenue growth for ten consecutive years.

36.35 0.02 +0.06%

Follow PCRX

Alert me

Market cap: $1.5B
P/E: 104×
Fwd P/E: 33.7×
Dividend yield: —
F-score: 8/9
Altman Z: 2.02
Beneish M: −2.93
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Jun '26	Mar '26	Dec '25	Sep '25	Older periods
ROE Full definition →	2.05%	0.71%	0.96%	2.90%	+8 more TTM periods Free account
Piotroski F-Score Full definition →	8	8	8	8
ROA Full definition →	1.05%	0.37%	0.50%	1.52%
ROIC Full definition →	1.58%	1.84%	1.45%	3.03%
Return on Tangible Assets Full definition →	2.35%	0.95%	1.24%	3.55%
Average Days of Receivables Full definition →	64.78	62.40	62.34	58.70
Free Cash Flow per Share Full definition →	4.55	3.28	3.07	2.82
Free Cash Flow Full definition →	179.52	132.71	136.66	124.20
Capital Expenditures Full definition →	(8.15)	(9.51)	(15.33)	(17.23)
Other line items
Cash ROIC Full definition →	13.96%	10.84%	10.48%	9.20%
Accounts Receivable Turnover Full definition →	6.05	6.38	6.12	6.64
Accounts Payable Turnover Full definition →	6.51	8.17	8.74	8.06
Inventory Turnover Full definition →	1.10	1.07	1.08	1.11
Average Days of Payables Full definition →	41.19	33.68	36.93	43.23
Days of Inventory on Hand Full definition →	316.59	361.43	372.59	385.39
Tax Rate Full definition →	(0.17)	(0.61)	(0.58)	(0.49)
Research and Development Expense of Revenue Full definition →	16.36%	16.34%	16.15%	14.43%
Selling, General and Administrative Expense of Revenue Full definition →	50.81%	51.16%	50.76%	48.38%
Share Based Compensation of Revenue Full definition →	7.50%	7.69%	7.92%	7.85%
Interest Coverage Full definition →	1.28	1.46	1.10	2.28
Operating CF/Net income Full definition →	12.82	27.68	21.61	6.60
Depreciation/Fixed assets Full definition →	0.64	0.66	0.63	0.59
Capex/Depreciation Full definition →	(0.10)	(0.11)	(0.17)	(0.20)
Revenue per Share Full definition →	18.91	18.16	16.30	16.28
Operating CF per Share Full definition →	4.76	3.51	3.41	3.21
Capex per Share Full definition →	(0.21)	(0.23)	(0.34)	(0.39)
Capex to Sales Full definition →	0.01	0.01	0.02	0.02

Fold the line items

Columns are period end dates

Stockrow Weekly